Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT03054038 · TERMINATED
Trial details
- NCT number
- NCT03054038
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-20
- Primary completion
- 2022-03-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.